fluoxetine has been researched along with Phobia, Social in 2 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Phobia, Social: Anxiety disorder characterized by the persistent and irrational fear, anxiety, or avoidance of social or performance situations.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barterian, JA | 1 |
| Sanchez, JM | 1 |
| Magen, J | 1 |
| Siroky, AK | 1 |
| Mash, BL | 1 |
| Carlson, JS | 1 |
| Vittengl, JR | 1 |
| Clark, LA | 1 |
| Smits, JAJ | 1 |
| Thase, ME | 1 |
| Jarrett, RB | 1 |
1 trial available for fluoxetine and Phobia, Social
| Article | Year |
|---|---|
An Examination of Fluoxetine for the Treatment of Selective Mutism Using a Nonconcurrent Multiple-Baseline Single-Case Design Across 5 Cases.
Topics: Adolescent; Child; Child, Preschool; Female; Fluoxetine; Humans; Male; Mutism; Phobia, Social; Selec | 2018 |
1 other study available for fluoxetine and Phobia, Social
| Article | Year |
|---|---|
Do comorbid social and other anxiety disorders predict outcomes during and after cognitive therapy for depression?
Topics: Adult; Antidepressive Agents, Second-Generation; Cognitive Behavioral Therapy; Comorbidity; Depressi | 2019 |